HRT FINANCIAL LP sold $11K of CMND
HRT FINANCIAL LP sold 3,183 shares of Clearmind Medicine Inc. (CMND) at $3.32 on 2026-06-15.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market sale of 3,183 shares by a 10% owner at $3.3200/share, totaling about $10.6k, with holdings after the trade of 103,492 shares.
Market read
Traders may monitor CMND for follow-on insider activity, but this specific disclosure is small and lacks fundamental catalysts.
What to watch
No 10b5-1 plan is cited, but the article also provides no context on total holdings, prior sales cadence, or whether the sale was tax-related—factors that can reduce interpretability.
Background
The article is an SEC Form 4 insider transaction disclosure for Clearmind Medicine Inc. (CMND).
Ticker impact
HRT Financial LP, a 10% owner, sold 3,183 shares of Clearmind Medicine (CMND) on 2026-06-15 at $3.3200/share via an open-market sale.
Near-term pressure is possible, but magnitude should be limited given the disclosure is a small Form 4 sale without new company fundamentals.
The filing is a Form 4 insider transaction (open-market sale) with no 10b5-1 plan and no accompanying operational/regulatory catalyst; such sales often have limited predictive power for price direction.
Market effects
Minimal; this is company-specific insider activity with no sector-wide signal.
None indicated.
None indicated.
Counterpoint
A 10% owner sale can be driven by diversification/liquidity needs rather than bearish fundamentals, especially without any accompanying negative news.
Key entities
- issuerClearmind Medicine Inc.
Subject of the Form 4 insider sale disclosure (CMND).
- insiderHRT Financial LP
10% owner who sold 3,183 shares in an open-market transaction.
